真皮填充劑市場規模、佔有率、成長分析（按材料、按產品、按地區）- 產業預測，2024-2031 年

2022年真皮填充劑市場規模為50.5億美元，從2023年的54.2億美元成長到2031年的96億美元，預測期間(2024-2031年)複合年成長率預計為7.4%。

由於皮膚過早老化案例的增加以及對微創手術選擇的日益偏好，全球真皮填充劑市場正在顯著成長。對皮膚填充劑手術的需求不斷增加、新興行業參與者的產品多樣化以及領先公司對產品認證不斷增加，進一步推動了這種快速成長。值得注意的是，男性注射填充劑採用率的上升是促進市場擴張的關鍵趨勢。儘管男性消費者目前在美容服務中佔少數，但他們的參與度正在成長，特別是在北美和歐洲，特別是在富裕的社會經濟群體中。資料顯示，2019年男性佔神經調節劑市場的10%，預計2031年將增加至15%。此外，真皮填充劑和生物促效劑的男性使用者預計將從 2019 年的 5% 增加到 2031 年的 7%。目前，調變器的市場滲透率約為 5%，真皮填充劑和生物促效劑的市場滲透率約為 4%。在美國，真皮填充劑市場預計在未來的預測期內將以有利的複合年成長率持續成長，反映出消費者人口結構和美容行業偏好的不斷變化。

目錄

介紹

• 研究目的
• 定義
• 市場範圍

調查方法

• 資訊採購
• 二手資料來源和主要資料來源
• 市場規模預測
• 市場假設與限制

執行摘要

• 市場概況展望
• 供需趨勢分析
• 按細分市場的機會分析

市場動態及展望

• 市場動態
  • 促進因素
  • 機會
  • 抑制因素
  • 任務
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 監管分析
• 案例研究分析
• 價格分析
• 臨床試驗
• 專利分析
• 技術分析

真皮填充劑市場：依材料分類

• 市場概況
• 玻尿酸
• 烴基磷灰石鈣
• 聚左旋乳酸
• PMMA（聚甲基丙烯酸甲酯）
• 脂肪填充劑
• 其他

真皮填充劑市場：依產品

• 市場概況
• 生物分解性
• 不可生物分解性

真皮填充劑市場：依應用分類

• 市場概況
• 疤痕治療
• 皺紋矯正治療
• 豐唇術
• 恢復體積/豐滿度
• 其他

真皮填充劑市場：依最終用戶分類

• 市場概況
• 專科/皮膚科診所
• 醫院/診所
• 其他

真皮填充劑市場規模：依地區

• 市場概況
• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲地區
• 中東和非洲 (MEA)
  • 海灣合作理事會國家
  • 南非
  • 其他中東/非洲地區

競爭格局

• 前5名企業對比
• 主要企業市場定位（2023年）
• 主要市場參與者所採取的策略
• 近期市集活動
• 主要企業市場佔有率（2023年）

主要企業簡介

• AbbVie Inc.（Allergan Plc）
• Galderma SA
• Medytox Inc.
• Merz Pharma GmbH & Co. KGaA
• Revance Therapeutics, Inc.
• Sinclair Pharma（Huadong Medicine Co., Ltd.）
• Teoxane Laboratories
• Suneva Medical, Inc.
• Laboratoires Vivacy SAS
• Prollenium Medical Technologies
• Cytophil, Inc.
• Bioxis Pharmaceuticals
• Laboratoires Fillmed
• Zimmer Aesthetic
• Anika Therapeutics, Inc.
• IBSA Nordic ApS
• Givaudan
• DSM
• Amalian
• Contura International Ltd.

Dermal Fillers Market size was valued at USD 5.05 billion in 2022 and is poised to grow from USD 5.42 billion in 2023 to USD 9.6 billion by 2031, growing at a CAGR of 7.4% in the forecast period (2024-2031).

The global dermal filler market is experiencing significant growth driven by increasing instances of early skin aging and a growing preference for minimally invasive surgical options. This surge is further propelled by heightened demand for dermal filler procedures, a greater variety of products from emerging industry players, and an uptick in product approvals by major companies. Notably, the rising adoption of injectable fillers among men is a key trend contributing to market expansion. Although male consumers currently represent a minority in aesthetic services, their participation is growing, particularly in North America and Europe, especially within affluent socioeconomic groups. Data indicates that men comprised 10% of the neuromodulator market in 2019, with projections suggesting this will increase to 15% by 2031. Additionally, male users of dermal fillers and biostimulators are expected to climb from 5% in 2019 to 7% by 2031. As of now, neuromodulators have a market penetration of approximately 5%, while dermal fillers and biostimulators sit at about 4%. In the U.S., the dermal fillers market is poised for sustainable growth at a favorable compound annual growth rate (CAGR) in the upcoming forecast period, reflecting the ongoing shifts in consumer demographics and preferences in the aesthetics industry.

Top-down and bottom-up approaches were used to estimate and validate the size of the Dermal Fillers market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Dermal Fillers Market Segmental Analysis

Global Dermal Fillers Market is segmented by Material, Product, Application, End Use, and region. Based on Material, the market is segmented into Hyaluronic Acid, Calcium Hydroxylapatite, Poly-L-lactic Acid, PMMA (Poly (Methyl Methacrylate)), Fat Fillers, and Others. Based on Product, the market is segmented into Biodegradable, and Non-Biodegradable. Based on Application, the market is segmented into Scar Treatment, Wrinkle Correction Treatment, Lip Enhancement, Restoration of Volume/Fullness, and Others. Based on End Use, the market is segmented into Specialty & Dermatology Clinics, Hospitals & Clinics, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Dermal Fillers Market

The rapid growth of the non-surgical dermatological procedures market is a significant driver for the dermal fillers market, fueled by their attractive benefits such as immediate results, cost-effectiveness, and a lower risk profile compared to invasive surgery. The rising societal emphasis on aesthetic enhancement and the desire for a youthful appearance have propelled the demand for these minimally invasive solutions. Injectable dermal fillers, which effectively address concerns like thin lips, facial contours, wrinkles, and scars, are becoming increasingly popular. In 2021, the substantial volume of non-surgical procedures, particularly an increase in demand among plastic surgeons, indicates a promising trajectory for the dermal fillers market.

Restraints in the Dermal Fillers Market

The high costs associated with dermal filler procedures, notably those involving fat face treatments and polymethyl-methacrylate microspheres, present significant market restraints for the dermal fillers sector. For instance, the average expense of polymethyl-methacrylate microspheres is approximately USD 1,058, while a fat face operation averages around USD 2,508, according to the American Society of Plastic Surgeons. Such substantial financial commitments may discourage potential patients, leading to slower adoption rates of these procedures. Consequently, the elevated price points are anticipated to hinder overall market expansion, limiting accessibility and curbing growth potential within the dermal fillers industry.

Market Trends of the Dermal Fillers Market

The dermal fillers market is witnessing a significant shift, with growing interest across diverse demographic groups, particularly among men seeking non-invasive aesthetic enhancements. As more men recognize the impact of aging and gravity on their facial appearance, demand for facial filler treatments is surging, attributed to their efficacy and minimal recovery time. According to the ISAPS Global Survey Results 2020, men accounted for approximately 12.2% of all global non-surgical procedures involving hyaluronic acid. This trend suggests a burgeoning patient base as dermatologists increasingly cater to male clients, propelling market growth and expanding opportunities for industry players throughout the forecast period.

Table of Contents

Introduction

• Objectives of the Study
• Definitions
• Market Scope

Research Methodology

• Information Procurement
• Secondary & Primary Data Sources
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Market Overview Outlook
• Supply Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Dynamics
  • Drivers
  • Opportunities
  • Restraints
  • Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of Substitute Products
  • Bargaining Power of Buyers
  • Threat of New Entrants
  • Bargaining Power of Suppliers

Key Market Insights

• Key Success Factor
• Degree of Competition
• Top Investment Pockets
• Ecosystem of the Market
• Regulatory Analysis
• Case Study Analysis
• Pricing Analysis
• Clinical Trials
• Patent Analysis
• Technology Analysis

Dermal Fillers Market, By Material

• Market Overview
• Hyaluronic Acid
• Calcium Hydroxylapatite
• Poly-L-lactic Acid
• PMMA (Poly (Methyl Methacrylate))
• Fat Fillers
• Others

Dermal Fillers Market, By Product

• Market Overview
• Biodegradable
• Non-Biodegradable

Dermal Fillers Market, By Application

• Market Overview
• Scar Treatment
• Wrinkle Correction Treatment
• Lip Enhancement
• Restoration of Volume/Fullness
• Others

Dermal Fillers Market, By End User

• Market Overview
• Specialty & Dermatology Clinics
• Hospitals & Clinics
• Others

Dermal Fillers Market Size by Region

• Market Overview
• North America
  • USA
  • Canada
• Europe
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America
  • Brazil
  • Rest of Latin America
• Middle East & Africa (MEA)
  • GCC Countries
  • South Africa
  • Rest of MEA

Competitive Landscape

• Top 5 Player Comparison
• Market Positioning of Key Players, 2023
• Strategies Adopted by Key Market Players
• Recent Activities in the Market
• Key Companies Market Share (%), 2023

Key Company Profiles

• AbbVie Inc. (Allergan Plc)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Galderma S.A.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medytox Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merz Pharma GmbH & Co. KGaA
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Revance Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sinclair Pharma (Huadong Medicine Co., Ltd.)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Teoxane Laboratories
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Suneva Medical, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoires Vivacy SAS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Prollenium Medical Technologies
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cytophil, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bioxis Pharmaceuticals
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Laboratoires Fillmed
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Aesthetic
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Anika Therapeutics, Inc.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• IBSA Nordic ApS
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Givaudan
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DSM
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Amalian
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Contura International Ltd.
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments